Existing antibacterial vaccines
N Mendoza, P Ravanfar, A Satyaprakah… - Dermatologic …, 2009 - Wiley Online Library
There are countless bacterial pathogens that cause disease in humans. Many of these
bacterial infections not only cause significant morbidity and mortality in the human …
bacterial infections not only cause significant morbidity and mortality in the human …
Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae …
I Tichmann-Schumann, P Soemantri… - The Pediatric …, 2005 - journals.lww.com
Background: The 7-valent pneumococcal (7vPn) conjugate vaccine is licensed for primary
and booster vaccination according to the same immunization schedules as routinely …
and booster vaccination according to the same immunization schedules as routinely …
[PDF][PDF] Development of novel vaccines using DNA shuffling and screening strategies
CP Locher, NW Soong, RG Whalen… - Current Opinion in …, 2004 - researchgate.net
DNA shuffling and screening technologies recombine and evolve genes in vitro to rapidly
obtain molecules with improved biological activity and fitness. In this way, genes from …
obtain molecules with improved biological activity and fitness. In this way, genes from …
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre …
AR Zanetti, L Romanò, C Giambi, A Pavan… - The Lancet Infectious …, 2010 - thelancet.com
Background In 2000, hexavac and infanrix hexa were licensed in Europe for primary
immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and …
immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and …
[HTML][HTML] An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and …
GL Morefield, RF Tammariello, BK Purcell… - Journal of immune …, 2008 - Springer
Background Combination vaccines reduce the total number of injections required for each
component administered separately and generally provide the same level of disease …
component administered separately and generally provide the same level of disease …
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada
JA Bettinger, SA Halperin, G De Serres… - The Pediatric …, 2007 - journals.lww.com
Background: Between July 1997 and April 1998, universal childhood immunization
programs in Canada changed from using a whole-cell pertussis to a 5-component acellular …
programs in Canada changed from using a whole-cell pertussis to a 5-component acellular …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and …
F Zepp, M Knuf, U Heininger, K Jahn, A Collard… - Vaccine, 2004 - Elsevier
Safety, reactogenicity and immunogenicity of GSK Biologicals' hexavalent DTPa–HBV–
IPV/Hib vaccine (Infanrix® hexa) was assessed when used for primary vaccination at 3, 4 …
IPV/Hib vaccine (Infanrix® hexa) was assessed when used for primary vaccination at 3, 4 …
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus …
JC Tejedor, M Moro, J Ruiz-Contreras… - The Pediatric …, 2006 - journals.lww.com
Background: This study evaluated the concurrent use of meningococcal C tetanus conjugate
(MenC-TT) vaccine (NeisVac-C) with DTaP-based combinations, according to 2 vaccination …
(MenC-TT) vaccine (NeisVac-C) with DTaP-based combinations, according to 2 vaccination …
Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy
A Zanetti, A Parlato, L Romanò, MG Desole, G Ferrera… - Vaccine, 2012 - Elsevier
BACKGROUND AND AIMS: The anamnestic response to a challenge dose of vaccine can
assess immune memory and protection against hepatitis B infection. This study investigated …
assess immune memory and protection against hepatitis B infection. This study investigated …